in Management of Biotech, Medtech
& Pharma Ventures

The Program

The objectives of this Certificate of Advanced Studies (CAS) program are to increase managerial competences and to raise competitive advantage in Life Sciences, particularly in Medtech, Biotech and Pharma Ventures.

It is aimed at  professionals in Medtech, Biotech, Pharma domains.


The CAS program is fully functional even though university campuses are closed across Switzerland. We have been proactive in shifting our courses to a digital format and have shifted all our current classes to remote live sessions for the duration of the coronavirus interruption.

We are continuing to accept and process applications in our normal, timely manner.

The CAS team is fully operational and available to answer any questions you may have, and wishes everyone the best of health.


If you want to undertake the CAS, you can start while the program is underway, completing the remaining modules the following year.

More information about the admissions process.


March 31-April 2, 2020

International intellectual property protection issues and strategies are highly important in domain such as medical devices, diagnostics, pharmaceuticals, biotechnology and generic. Strategic issues of IP and how patent, trade mark, etc. are created, managed and enforced will be addressed.


May 5-7 2020

Getting the authorizations and approvals for new medicines and devices is critical. The module will address how to manage and carry out clinical trials, while respecting the legislative framework. It covers good practices management and the regulations applying to medical devices & therapeutics.


May 26-28, 2020

Manufacturing facilities occupy a growing share of an enterprise’s strategic horizon. Planning, design, construction, qualification, validation and operation are key steps to deliver a production facility. Quality systems, GMP and their impact on Medtech and Biotech new process validation will be addressed.


June 16-18, 2020

The development of new devices and medicines is a long process. A thorough planning of different steps/ milestones of the project is key for reaching success. You will learn how to give project solid foundations, with due considerations for stakeholders, precise objectives and key success factors.


Jan 19-21, 2021

Enterprises in life sciences need considerable amounts of resources. Alliances, partnerships or outsourcing are often required for success. This module provides a framework to select partners; to identify the appropriate form of partnership (joint-venture, alliance or outsourcing) and to implement it.


Feb 9-11, 2021

Understanding the challenges and opportunities in data and the strategies around data are highly important in domain such as medical devices, diagnostics, pharmaceuticals, biotechnology and generic pharma. Strategic issues of how to approach opportunities with data at the heart and how projects are created, managed and delivered with value in different systems will be addressed.


April 13-15, 2021

The key challenge in life sciences sector is to grow the business in increasingly competitive & global markets. With this module you will grasp the global market environment (customers, competitors, channels); improve your command of concepts & methods to design/ implement marketing strategies.

* Dates of modules may be subject to change 


These modules address key managerial issues and are led by top European Professors and Executives from Industry. They are be case study oriented.

Program participation is flexible. Participants can choose to follow the whole program or select the modules they have an interest in.

Tuition Fees

Per module 2 modules 3 modules 4 modules
CHF 2’450 CHF 4’400 CHF 6’050 CHF 7’400


5 modules 6 modules 7 modules
CHF 8’450 CHF 9’200 CHF 9’650


Although it is possible to take the CAS over two years, the progressive pricing as stated above is only applicable if the full amount is paid in the first year, by June 30th. (Example: taking two modules year 1 and three modules year two means a payment of CHF 8’450 if paid in the first year, versus CHF 4’400 year 1 and CHF 6’050 year 2).


CAS in Management of BioTech, MedTech and Pharma ventures allowed me to deepen my knowledge of regulated industries and gain multiple valuable industry connections. It is an excellent program and I recommend it anyone who wants to gain valuable insights in Bio-pharmaceutical and Medical Device Industry, and benefit from a remarkable selection of speakers.

Ksenia Tugay
Aston Life Sciences

Being an engineer in a medical device company is not only technically challenging but it requires knowledge in the fields of Quality and Regulatory, IP, Project Management and Marketing/ Sales, exactly the 5 modules I chose.  Many real-life examples and experiences were shared and this gave the lectures the “non-academic” character that suited better the expectations of the majority of the participants.
I would definitely recommend it to any professional that would like either to get a good idea of the challenges in these very important fields or even refresh any existing knowledge.

Efie Mavraki
Development & Design Assurance Engineer
ALEVA Neurotherapeutics SA

The CAS course helped me to extend my MedTech/Biotech knowhow to unknown areas such as Clinicals Trials and Strategic Alliances. Complemented by relevant cases studies, this course will be for sure an asset in my career going forward.

Marc Moal
Director Product Delivery,
Merck Group